STEVEN CRAIN
Psychologist in State College, PA
License number
Pennsylvania PS003883L
Category
Psychology
Type
Psychologist
Address
Address
State College, PA 16801
Professional information
Steven Crain, State College PA
Specialties:
Psychologist
Address:
315 S Allen St, State College, PA 16801
Methods And Compositions For Treating Distress Dysfunction And Enhancing Safety And Efficacy Of Specific Medications
US Patent:
8202525, Jun 19, 2012
Filed:
Dec 20, 2010
Appl. No.:
12/973839
Inventors:
Steven Crain - State College PA, US
William E. Crain - Pownal ME, US
Stanley M. Crain - State College PA, US
Michael Crain - Essex CT, US
William E. Crain - Pownal ME, US
Stanley M. Crain - State College PA, US
Michael Crain - Essex CT, US
Assignee:
Pondera Biotechnologies, LLC - Pownal ME
International Classification:
A61K 9/00, A61K 38/00
US Classification:
424400, 514 175
Abstract:
The present invention relates to methods and compositions for reducing distress dysfunction, including emotional and physical distress. The invention entails co-administration of at least one Receptor Switcher and at least one Endorphin Enhancer. Additionally, at least one Synergistic Enhancer and/or at least one Exogenous Opioid are also administered to enhance or prolong the therapeutic effects.
Methods And Compositions For Treating Distress Dysfunction And Enhancing Safety And Efficacy Of Specific Medications
US Patent:
8372414, Feb 12, 2013
Filed:
Apr 30, 2012
Appl. No.:
13/460467
Inventors:
Steven Crain - State College PA, US
William E. Crain - Pownal ME, US
Stanley M. Crain - State College PA, US
Michael Crain - Essex CT, US
William E. Crain - Pownal ME, US
Stanley M. Crain - State College PA, US
Michael Crain - Essex CT, US
Assignee:
Pondera Biotechnologies, LLC - Pownal MA
International Classification:
A61K 9/00
US Classification:
424400
Abstract:
The present invention relates to methods and compositions for reducing distress dysfunction, including emotional and physical distress. The invention entails co-administration of at least one Receptor Switcher and at least one Endorphin Enhancer. Additionally, at least one Synergistic Enhance and/or at least one Exogenous Opioid are also administered to enhance or prolong the therapeutic effects.